1. P36 Serum immunoglobulin levels and risk of serious infections in the pivotal phase III trials of ocrelizumab in multiple sclerosis and their open-label extensions. Issue 4 (April 2020) Authors: Derfuss, T.; Weber, M.; Hughes, R.; Eggebrecht, J.; Wang, Q.; Sauter, A.; Koendgen, H.; Hauser, S.; Bar-Or, A.; Hartung, H.P. Journal: Clinical neurophysiology Issue: Volume 131:Issue 4(2020:Apr.) Page Start: e196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Surface‐Mediated Priming During In Vitro Generation of Monocyte‐Derived Dendritic Cells. (January 2015) Authors: Sauter, A.; Mc Duffie, Y.; Boehm, H.; Martinez, A.; Spatz, J. P.; Appel, S. Journal: Scandinavian journal of immunology Issue: Volume 81:Number 1(2015:Jan.) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗